Latest & greatest articles for pregnancy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pregnancy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pregnancy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pregnancy

1. Are healthy weight management interventions effective before, during and after pregnancy?

Are healthy weight management interventions effective before, during and after pregnancy? Knowledge & Library Services (KLS) Evidence Briefing Are healthy weight management interventions effective before, during and after pregnancy? Nicola Pearce-Smith 2nd October 2019 What is the evidence for effective healthy weight management interventions before, during and after pregnancy? KLS Evidence Briefing 2 nd October 2019 Question This briefing summarises the evidence for effective healthy weight (...) management interventions before, during and after pregnancy, including those that reduce gestational weight gain (GWG) or prevent poor maternal and child health outcomes, from January 1 st 2010 to 19 th Sept 2019. Key messages • There were many systematic reviews addressing this topic, but there was no overall consensus on which interventions are the most effective for healthy weight management in pregnant or postpartum women • Some reviews found that dietary interventions alone were significantly more

2020 Publication 4890972

2. Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial

Restrictive versus routine episiotomy among Southeast Asian term pregnancies: a multicentre randomised controlled trial Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation BJOG Actions , 127 (3), 397-403 Feb 2020 Restrictive Versus Routine Episiotomy Among Southeast Asian Term Pregnancies: A Multicentre Randomised Controlled Trial , , , , , , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynaecology, Khon Kaen Hospital, Khon Kaen, Thailand. 2

2020 EvidenceUpdates

3. Diabetes in Pregnancy

Diabetes in Pregnancy Guideline No. 393-Diabetes in Pregnancy - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 41, Issue 12, Pages 1814–1825.e1 Guideline No. 393-Diabetes in Pregnancy x Howard Berger Correspondence Corresponding author: Dr. Howard Berger , MD x Howard Berger Correspondence Corresponding author: Dr. Howard Berger Toronto, ON x Robert Gagnon , MD Montréal, QC x Mathew Sermer , MD Toronto, ON No. 393 (...) , December 2019 (replaces No. 334, July 2016) DOI: To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Figures Appendix A Gestational Diabetes Mellitus Screening and Diagnosis Appendix B Gestational Diabetes Mellitus Postpartum Testing Abstract Objectives This guideline reviews the evidence relating to the diagnosis and obstetrical management of diabetes in pregnancy. Outcomes The outcomes evaluated were short and long-term maternal outcomes

2020 Society of Obstetricians and Gynaecologists of Canada

4. Maternal Collapse in Pregnancy and the Puerperium

Maternal Collapse in Pregnancy and the Puerperium Maternal Collapse in Pregnancy and the Puerperium - Chu - - BJOG: An International Journal of Obstetrics & Gynaecology - Wiley Online Library

Full Text available with Trip Pro

2020 Royal College of Obstetricians and Gynaecologists

5. Antiepileptics and pregnancy: potential long-term effects in children

Antiepileptics and pregnancy: potential long-term effects in children Prescrire IN ENGLISH - Spotlight ''Antiepileptics and pregnancy: potential long-term effects in children'', 1 January 2020 {1} {1} {1} | | > > > Antiepileptics and pregnancy: potential long-term effects in children Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Antiepileptics (...) and pregnancy: potential long-term effects in children FEATURED REVIEW Many women who could become pregnant are exposed to antiepileptic drugs. Yet most of the antiepileptic drugs taken by pregnant women expose the unborn child to the risk of malformations, fetotoxic effects and neonatal disorders. What are the long-term effects of the most widely used antieleptics on children exposed in utero, and how do they compare? Full review (8 pages) available for download by subscribers. Abstract What are the main

2020 Prescrire

6. AmnioSense for unexplained vaginal wetness in pregnancy

AmnioSense for unexplained vaginal wetness in pregnancy AmnioSense for unexplained vaginal wetness in pregnancy Medtech innovation briefing Published: 26 November 2019 www.nice.org.uk/guidance/mib198 pathways Summary Summary The technology technology described in this briefing is AmnioSense. It is used for identifying leaking amniotic fluid in pregnant women with unexplained vaginal wetness. The inno innovativ vative aspects e aspects are that AmnioSense is a non-invasive test that uses a pH (...) pregnancy. Vaginal wetness can result from leaking amniotic fluid and may indicate amniotic membrane rupture. Premature membrane rupture needs urgent medical attention. AmnioSense attaches to underwear and can be worn for up to 12 hours. The liner has a central polymer-embedded strip which changes colour when it comes into contact with fluid of pH 6.5 or higher. A healthy vagina has a pH value of 3.5 to 4.5 but amniotic fluid and urine have pH values higher than 6.5. When in contact with urine

2019 National Institute for Health and Clinical Excellence - Advice

7. Continuous Glucose Monitoring in Pregnancy

Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy - Health Technology Wales > Continuous Glucose Monitoring in Pregnancy Continuous Glucose Monitoring in Pregnancy Topic Status Incomplete Continuous glucose monitoring systems for managing diabetes in pregnant women. Summary Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of continuous glucose monitoring as an aid to managing diabetes for pregnant women. Based

2019 Health Technology Wales

8. Termination of pregnancy

Termination of pregnancy Maternity and Neonatal C linical G uideline Queensland Health Termination of pregnancy Queensland Clinical Guideline: Termination of pregnancy Refer to online version, destroy printed copies after use Page 2 of 32 Document title: Termination of pregnancy Publication date: April 2013 Document number: MN13.21-V3-R19 Document supplement: The document supplement is integral to and should be read in conjunction with this guideline. Amendments: Full version history (...) : Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Termination of pregnancy Refer to online version, destroy printed copies after use Page 3 of 32 Flow Chart: Summary of termination of pregnancy Queensland Clinical Guidelines: Summary of termination of pregnancy Flowchart: F13.21-1-V3-R19 Legal requirements ToP Act 2018 Less than or equal to 22+0 weeks · A medical practitioner may perform

2019 Queensland Health

9. Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care

Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians

2019 Society of Obstetricians and Gynaecologists of Canada

10. Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care

Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care Toggle navigation Toggle search Keyword search language Keyword search Pregnancy and Maternal Obesity Part 1: Pre-conception and Prenatal Care If you are not automatically redirected to the JOGC site within 15 seconds, please click the link above. No information available ID Access The Society of Obstetricians and Gynaecologists of Canada (SOGC) {1} {1

2019 Society of Obstetricians and Gynaecologists of Canada

11. Pregnancy and Renal Disease

Pregnancy and Renal Disease Clinical Practice Guideline Pregnancy and Renal Disease Authors: Kate Wiles - Chair NIHR Doctoral Research Fellow in Obstetric Nephrology, Guy’s and St. Thomas’ NHS Foundation Trust and King's College London Lucy Chappell Professor of Obstetrics, King's College London and Consultant Obstetrician, Guy’s and St. Thomas’ NHS Foundation Trust Katherine Clark Specialist Midwife, King’s College Hospital NHS Foundation Trust Louise Elman Expert Patient Matt Hall Consultant (...) Nephrologist, King’s College Hospital NHS Foundation Trust and King’s College London Final Version: September 2019 Review Date: September 2024 Renal Association Clinical Practice Guideline Pregnancy and Renal Disease – September 2019 2 Endorsements The National Institute for Health and Care Excellence (NICE) has accredited the process used by the Renal Association to produce its Clinical Practice Guidelines. Accreditation is valid for 5 years from January 2017. More information on accreditation can

2019 Renal Association

12. Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer

Association Between Pregnancy Outcomes and Radioactive Iodine Treatment After Thyroidectomy Among Women With Thyroid Cancer Current guidelines recommend that women delay pregnancy for 6 to 12 months after the receipt of radioactive iodine treatment (RAIT) following thyroidectomy for differentiated thyroid carcinoma. Although concerns exist regarding the risks associated with pregnancy after RAIT, no large-scale study, to date, has investigated the association between RAIT and pregnancy (...) outcomes.To investigate whether RAIT was associated with increases in adverse pregnancy outcomes among South Korean women who received RAIT after thyroidectomy for thyroid cancer and to evaluate the appropriate interval between RAIT and conception.This population-based cohort study used the Health Insurance Review and Assessment database of South Korea to identify a total of 111 459 women of childbearing age (20-49 years) who underwent thyroidectomy for the treatment of differentiated thyroid carcinoma

2019 EvidenceUpdates

13. Regimens of vitamin D supplementation for women during pregnancy. (PubMed)

Regimens of vitamin D supplementation for women during pregnancy. Vitamin D deficiency during pregnancy increases the risk of pre-eclampsia, gestational diabetes, preterm birth, and low birthweight. In a previous Cochrane Review we found that supplementing pregnant women with vitamin D alone compared to no vitamin D supplementation may reduce the risk of pre-eclampsia, gestational diabetes, and low birthweight and may increase the risk of preterm births if it is combined with calcium. However (...) the effects of different vitamin D regimens are not yet clear.To assess the effects and safety of different regimens of vitamin D supplementation alone or in combination with calcium or other vitamins, minerals or nutrients during pregnancy, specifically doses of 601 international units per day (IU/d) or more versus 600 IU/d or less; and 4000 IU/d or more versus 3999 IU/d or less.We searched the Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials

2019 Cochrane

14. Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines

Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines Buprenorphine (...) for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines Last updated: May 9, 2019 Project Number: RC1111-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the comparative clinical effectiveness of various buprenorphine or buprenorphine-naloxone formulations versus other buprenorphine formulations for the treatment of opioid use disorders during pregnancy

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

15. Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost (...) -Effectiveness, and Guidelines Pregnancy Testing for Patients Requiring Diagnostic Imaging or Surgery in the Emergency Department: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: May 28, 2019 Project Number: RB1345-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of performing a pregnancy test prior to diagnostic imaging or surgery in the emergency department setting? What

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

16. Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines

Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the First Stage of Labor: Clinical Effectiveness and Guidelines Last updated: September 9, 2019 Project Number (...) : RB1393-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure to progress in the latent phase of labor? What are the benefits and harms of caesarean delivery for Robson group 2A pregnancies with failure to progress in the latent phase of labor? What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

17. Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines

Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Caesarean Delivery for Pregnancies in the Second Stage of Labor: Clinical Effectiveness and Guidelines Last updated: September 16, 2019 Project (...) Number: RB1394-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the benefits and harms of caesarean delivery for Robson group 1 pregnancies with failure to progress in the second stage of labour? What are the benefits and harms of caesarean delivery for Robson group 2A pregnancies with failure to progress in the second stage of labour? What are the evidence-based guidelines regarding the use of caesarean delivery for Robson

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

18. Withdrawal Management and Treatment of Crystal Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines

Withdrawal Management and Treatment of Crystal Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines Withdrawal Management and Treatment of Crystal Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Withdrawal Management and Treatment of Crystal Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines Withdrawal Management and Treatment of Crystal (...) Methamphetamine Addiction in Pregnancy: A Review of Clinical Effectiveness and Guidelines Last updated: June 17, 2019 Project Number: RC1130-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of interventions for the withdrawal management or treatment of persons who are pregnant and addicted to crystal methamphetamine? What are the evidence-based guidelines regarding withdrawal management

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

19. UK guidelines on the management of iron deficiency in pregnancy

UK guidelines on the management of iron deficiency in pregnancy UK guidelines on the management of iron deficiency in pregnancy - Pavord - - British Journal of Haematology - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Guideline Free Access UK guidelines on the management of iron deficiency in pregnancy Department of Haematology, Oxford University Hospitals, Oxford, UK Women's Health Research (...) . I have read and accept the Wiley Online Library Terms and Conditions of Use. Shareable Link Use the link below to share a full-text version of this article with your friends and colleagues. Copy URL Share a link Share on ). The prevalence of anaemia in pregnancy remains high. In order to minimise adverse outcomes, including use of blood transfusion, further research is required to define optimal management, as many current recommendations are not supported by high quality evidence. Methods

2019 British Committee for Standards in Haematology

20. Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies

Non-invasive prenatal testing to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies 1 Translation of the key statement of the final report S16-06 Nicht invasive Pränataldiagnostik (NIPD) zur Bestimmung des Risikos autosomaler Trisomien 13, 18 und 21 bei Risikoschwangerschaften (Version 1.0; Status: 30 April 2018). Please note: This document was translated by an external translator and is provided as a service by IQWiG to English-language readers. However, solely (...) the German original text is absolutely authoritative and legally binding. Extract IQWiG Reports – Commission No. S16-06 Non-invasive prenatal testing (NIPT) to determine the risk of autosomal trisomies 13, 18 and 21 in high-risk pregnancies 1 Extract of final report S16-06 Version 1.0 Non-invasive prenatal testing (NIPT) 30 April 2018 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Non-invasive

2019 Institute for Quality and Efficiency in Healthcare (IQWiG)